Literature DB >> 2422051

Normal and abnormal aspects of proteinuria. Part I: Mechanisms, characteristics and analyses of urinary protein. Part II: Clinical considerations.

E P Lillehoj, M D Poulik.   

Abstract

Part I highlights the mechanisms of glomerular filtration and tubular reabsorption of plasma proteins, selected characteristics of urinary proteins based upon electrophoretic properties and recent advances in clinical laboratory analysis of proteinuria. Both structural characteristic of the glomerular capillary wall and molecular properties of plasma proteins are important determinants of glomerular filtration. Proteins filtered by the glomerulus subsequently appear in urine only after escaping the efficient mechanisms of tubular reabsorption. Albumin is one such protein and constitutes the major protein in normal urine although trace amounts of alpha, beta, and gamma globulins are also detectable. Several techniques of protein analysis have thus been developed to specifically measure albumin as well as other plasma proteins. Other methods have been adapted to measure total urinary protein content enabling the clinician to readily monitor renal function in health and disease. The second part of this review will consider conditions associated with proteinuria in both asymptomatic individuals and patients with renal disease. Asymptomatic proteinuria encompasses states of excess protein excretion during conditions of orthostasis, exercise, travel to high altitude of fever. Proteinuria during renal disease has received considerable interest as a means to monitor kidney function. It is therefore classified according to the type of damage incurred: (1) glomerular-type where large molecular weight proteins are excreted (2) tubular-type where small molecular weight proteins are excreted and (3) mixed-type characterized by both large and small molecular weight proteinuria.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422051     DOI: 10.1016/s0232-1513(86)80002-0

Source DB:  PubMed          Journal:  Exp Pathol        ISSN: 0232-1513


  7 in total

1.  Electrophoretic analysis of urinary proteins in diabetic adolescents.

Authors:  G Koliakos; F Papachristou; M Papadopoulou; V Trachana; M Gaitatzi; I Sotiriou
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Urinary protein analysis in pre- and postoperative cancer patients.

Authors:  Kayo Yokomizo; Shiro Iijima; Nobue Sakai; Yuriko Kurihara; Nobuo Hitratsuka; Kagami Nagai; Takehisa Iwai; Kiyoko Shiba
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  Sportomics suggests that albuminuria is a sensitive biomarker of hydration in cross combat.

Authors:  Luis C O Gonçalves; Anibal M Magalhães-Neto; Adriana Bassini; Eduardo Seixas Prado; Renan Muniz-Santos; Marcio V A Verli; Lukas Jurisica; Jaqueline S S Lopes; Igor Jurisica; Claudia M B Andrade; L C Cameron
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

4.  Proteinuria after renal transplantation: diagnosis with highly sensitive silver stain in sodium dodecylsulphate-polyacrylamide gradient gel electrophoresis.

Authors:  M Kirschstein; R Jensen; R Schröder; K Sack
Journal:  Klin Wochenschr       Date:  1991-11-15

5.  Contribution to the aetiopathogenesis of orthostatic proteinuria in children: relation to the upper calyx syndrome.

Authors:  M Zibolen; M Minárik; J Buchanec; S Beláková
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 6.  Identification and management of albuminuria in the primary care setting.

Authors:  Louis Kuritzky; Robert Toto; Peter Van Buren
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-02-01       Impact factor: 3.738

7.  Characterization of Proteinuria in Dogue de Bordeaux Dogs, a Breed Predisposed to a Familial Glomerulonephropathy: A Retrospective Study.

Authors:  Rachel Lavoué; Catherine Trumel; Pascale M Y Smets; Jean-Pierre Braun; Luca Aresu; Sylvie Daminet; Didier Concordet; Florence Palanché; Dominique Peeters
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.